Czech and Slovak Ophthalmology 182 10.31348/2021/X02 Original article Visual Field Assessment in Hypertension Glaucoma Lešták Ján https://orcid.org/0000-0001-9630-3441 Fůs Martin https://orcid.org/0000-0003-3245-4544 11 3 2021 1 3

Aims: The aim of the work is to verify the necessity of full-field perimetry test in incipient glaucoma. Material and methods: The study included group of 16 incipient hypertension glaucoma (HTG group) patients without obvious changes in visual field and control group of 10 patients with normal ocular findings and value 1.0 of visual acuity. In both groups, full-field perimetry test was performed followed by a glaucoma perimetry test (rapid threshold strategy in both cases). Evaluated parameters were pattern defect (PD) and overall defect (OD) using Pearson’s correlation coefficient. Results: Strong correlation coefficient between PD (r = 0.74) and OD (r = 0.63) of both perimetry test were found in HTG group. Moderate correlation of PD (r = 0.54) and strong correlation of OD (r = 0.64) in control group. Conclusion: Results of the study shows, that expected changes of peripheral visual field will be recorded first in HTG group, but opposite is true. Perimetry glaucoma test is for incipient glaucoma sufficient to document the course and the examination of glaucoma disease.

 hypertension glaucoma perimetry test pattern defect overall defekt References Bonomi L, Marchini G, Marraffa M. et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population.The Egna-Neumarkt Study. Ophthalmology. 1998;105: 209–215. Klein BE, Klein R, Sponsel WE. et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992;99:1499-1504. Araie M, Yamagami J, Suziki Y. Visual field defects in normal-tension and high-tension glaucoma. Ophthalmology. 1993;100:1808– 1814. Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980;24:621–664. Zeiter JH, Shin DH, Juzych MS, Jarvi TS, Spoor TC, Zwas F. Visual field defects in patients with normal-tension glaucoma and patients with high-tension glaucoma. Am J Ophtalmol. 1992;114:758– Caprioli J, Spaeth GL. Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Amer J Ophthalmol. 1984;97:730–737. Lestak J, Nutterova E, Bartosova L, Rozsival P. The visual field in normal tension glaucoma and hypertension glaucoma. IJSR. 2014;3: 49–51. Rojas B, Gallego BI, Ramírez AI. et al. Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers. J Neuroinflammation. 2014;11:133. doi:10.1186/1742-2094-11-133.10.1186/1742-2094-11-133 Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci.1991;32:484–491. Morgan JE, Uchida H, Caprioli J. Retinal ganglion cell death in experimental glaucoma. Br J Ophthalmol. 2000;84:303–310. Naskar R, Wissing M, Thanos S. Detection of Early Neuron Degeneration and Accompanying Microglial Responses in the Retina of a Rat Model of Glaucoma. Invest Ophthalmol Vis Sci. 2002;43:2962– 2968. Shou T, Liu J, Wang W, Zhou Y, Zhao K. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci. 2003;44: 3005–3010. Smith EL, Chino YM, Harwerth RS, Ridder WH, Crawford MLJ, De- Santis L. Retinal inputs to the monkey’s lateral geniculate nucleus in experimental glaucoma. Clin Vision Sci. 1993;8:113–139. Chaturvedi N, Hedley–Whyte ET, Dreyer EB. Lateral geniculate nucleus in glaucoma. Am J Ophthalmol. 1993;116:182–188. Vickers JC, Hof RP, Schumer RA, Wang RF, Podos SM, Morrison JH. Magnocellular and parvocellar visual pathways are both affected in a macaque model of glaucoma. Aust N Z J Ophthalmol. 1997;25:239–243. Quigley HA, Sanchez RM, Dunkelberger GR, L’Hernault NL, Baginski TA. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci. 1987;28:913–920. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453–464. Keltner JL, Johnson ChA,; Quigg JM. et al. Confirmation of Visual Field Abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2000;118:1187–1194. Heijl A, Patella VM. The field analyser primer. Essential perimetry. Third edition. Carl Zeiss Meditec Inc. 2002. ISBN: 0-9721560-0-3., s. 26 Heijl A, Patella VM, Bengtsson B. The field analyser primer. Essential perimetry. Fourth edition. Carl Zeiss Meditec Inc. 2012. ISBN: 0-9884795-0-8, s. 29. Skalicky SE. Ocular and visual physiology. Clinical application. Springer Science+Business Media Singapore Pte Ltd., Australia 2016, Chapter 8, p. 123. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41:741–748. Klamann MK, Grünert A, Maier AK, Gonnermann J, Joussen AM, Huber KK. Comparison of functional and morphological diagnostics in glaucoma patients and healthy subjects. Ophthalmic Res. 2013;49:192–198. Zakova M, Lestak J, Fus M, Maresova K. OCT Angiography and Visual Field in Hypertensive and Normotensive Glaucoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020;164 – in press Lešták J, Pitrová Š. „Ganglion cells komplex“ a vrstva nervových vláken u hypertenzních a normotenzních glaukomů. [Ganglion Cells Complex“ and Retinal Nerve Fiber Layer in Hypertensive and Normal-Tension Glaucoma]. Cesk Slov Oftalmol. 2016;72:199–203. Czech. Na JH, Lee K, Lee JR, Baek S, Yoo SJ, Kook MS. Detection of macular ganglion cell loss in preperimetric glaucoma patients with localized retinal nerve fibre defects by spectral-domain optical coherence tomography. Clin Exp Ophthalmol. 2013;41: 870–880. Ma ZW, Qiu WH, Zhou DN, Yang WH, Pan XF, Chen H. Changes in vessel density of the patients with narrow antenior chamber after an acute intraocular pressure elevation observed by OCT angiography. BMC Ophthalmol. 2019;19:132. doi: 10.1186/s12886-019- 1146-610.1186/s12886-019- In JH, Lee SY, Cho SH, Hong YJ. Peripapillary Vessel Density Reversal after Trabeculectomy in Glaucoma. J Ophthalmol. 2018;26:8909714. doi: 10.1155/2018/8909714. eCollection 2018.10.1155/2018/8909714 Sommer A, Katz J, Quigley HA, Miller NR, Robin AL, Richter RC, Witt KA.Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109:77–83. Bosworth CF, Sample PA, Weinreb RN. Motion perception thresholds in areas of glaucomatous visual field loss. Vision Res. 1997;37:355–364. Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry.Invest Ophthalmol Vis Sci. 1997;38:413–425. Arend KO, Plange N. Diagnostic approaches for early detection of glaucoma progression. Klin Monbl Augenheilkd. 2006;223:194–216. Ferreras A, Polo V, Larrosa JM. et al. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma? J Glaucoma. 2007;16:372–383. Nomoto H, Matsumoto C, Takada S. et al. Detectability of glaucomatous changes using SAP, FDT, flicker perimetry, and OCT. J Glaucoma. 2009;18:165–171. Horn FK, Jonas JB, Korth M, Jünemann A, Gründler A.The fullfield flicker test in early diagnosis of chronic open-angle glaucoma. Am J Ophthalmol. 1997;123:313–319. Horn FK, Tornow RP, Jünemann AG, Laemmer R, Kremers J. Perimetric measurements with flicker-defined form stimulation in comparison with conventional perimetry and retinal nerve fiber measurements. Invest Ophthalmol Vis Sci. 2014;55:2317–2323. Lešták J, Fůs M. Neuroprotection in glaucoma-electrophysiology. Exp Ther Med. 2020;19:2401–2405.